Conference abstract · 2022
Review articlePublished 2012
Reactive Oxygen Species Reduction is a Key Underlying Mechanism of Drug Resistance in Cancer Chemotherapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Reactive Oxygen Species (ROS) management in cancer cells is important for developing successful therapy. Most of the anticancer agents induce ROS generation to kill cancer cells by apoptosis through common molecular pathways. But prolonged treatment with the drug reduces ROS level to confer resistance. Subsequently, drug resistant cells have lower ROS content than drug sensitive cancer cells. Anticancer drugs induce master regulatory genes and these genes act on NFE2L2-KEAP1 antioxidant system to reduce the ROS level in cancer cells. This review focused on the genetic mechanism of drug mediated induction of ROS generation in sensitive cells and the ROS reduction in drug resistant cancer cells.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2016
Nitric Oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective
Research article · 2014
Ritonavir: A Powerful Boosting Agent for Overcoming Drug Resistance in Cancer Chemotherapy
Case report · 30 Aug 2023
Resistance to Chemotherapy in Uterine Cancer: Mechanisms and Current therapies for Systemic treatment of Gynaecologic Malignancies
Review article · 2012
The Protein Kinase A (PKA) Intracellular Pathway and Androgen Receptor: A Novel Mechanism Underlying the Castration-resistant and Metastatic Prostate Cancer
More from this journal
The newest in Chemotherapy: Open Access.
Perspective · 3 Nov 2025
Vulvar and Vaginal Cancers Clinical Characteristics Treatment Options and Prognosis
Opinion · 3 Nov 2025
Evaluation of Surgical Radiotherapy and Chemotherapy in the Treatment of Gynaecological Malignancies
Research article · 18 Aug 2025
Response Evaluation to Oxaliplatin-Based Adjuvant Chemotherapy after Curative Resection between Right and Left-Sided Stage II and III Colon Cancer: A Retrospective Survival Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemotherapy: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Amit K. Maiti”

